|
221 |
Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study Enthalten in Trials Bd. 20, 16.4.2019, Nr. 1, date:12.2019: 1-10
|
|
|
222 |
What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs Enthalten in Arthritis Research & Therapy Bd. 10, 7.2.2008, Nr. 1, date:2.2008: 1-16
|
|
|
223 |
Why Do People Become Involved With Archaeology? Some Answers from Alabama’s Black Belt Region Enthalten in Archaeologies Bd. 7, 31.12.2011, Nr. 3, date:12.2011: 538-553
|
|